REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure
Clinical trial NCT05353166 · COMPLETED
Trial details
- NCT number
- NCT05353166
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2025-06-02
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.